Birte Kulemann
Overview
Explore the profile of Birte Kulemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
752
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, et al.
N Engl J Med
. 2025 Jan;
392(4):323-335.
PMID: 39842010
Background: The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy. Methods: In this phase 3,...
2.
Doll P, Bolm L, Braun R, Honselmann K, Deichmann S, Kulemann B, et al.
Pancreatology
. 2023 Aug;
23(6):689-696.
PMID: 37532635
Background/objectives: The aim of this study was to evaluate the impact of perioperative fluid administration in pancreatic surgery. Methods: Patients who underwent pancreatic resections were identified from our institution's prospectively...
3.
Kuvendjiska J, Muller F, Bronsert P, Timme-Bronsert S, Fichtner-Feigl S, Kulemann B
Life (Basel)
. 2023 Jul;
13(7).
PMID: 37511945
Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cyst and a precursor of pancreatic cancer (PDAC). Since PDAC has a devastatingly high mortality rate, the early diagnosis and...
4.
Braun C, Schmoor C, Timme-Bronsert S, Fichtner-Feigl S, Hoeppner J, Kulemann B, et al.
J Cancer
. 2023 Jul;
14(11):2152-2160.
PMID: 37497409
Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently needed. A promising field is liquid biopsy, meaning the investigation of...
5.
Abdalla T, Klinkhammer-Schalke M, Zeissig S, Tol K, Honselmann K, Braun R, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(11):8535-8543.
PMID: 37095413
Objective: The available literature regarding outcome after pancreatic resection in locally advanced non-functional pNEN (LA-pNEN) is sparse. Therefore, this study evaluates the current survival outcomes and prognostic factors in after...
6.
Gebauer N, Ziehm M, Gebauer J, Riecke A, Meyhofer S, Kulemann B, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358883
Background: Across a variety of solid tumors, prognostic implications of nutritional and inflammation-based risk scores have been identified as a complementary resource of risk stratification. Methods: In this retrospective study,...
7.
Deichmann S, Dworschak O, Kulemann B, Hoppner J, Bolm L, Klinkhammer-Schalke M, et al.
Zentralbl Chir
. 2022 Apr;
147(2):147-154.
PMID: 35378553
Background: In recent years, there have been changes in the treatment of ductal pancreatic carcinoma with regard to multimodal therapy and also surgical therapy. These changes have not yet been...
8.
Joechle K, Jumaa H, Thriene K, Hellerbrand C, Kulemann B, Fichtner-Feigl S, et al.
Front Cell Dev Biol
. 2022 Jan;
9:785979.
PMID: 35096817
Cholangiocarcinoma (CCA) is a rare but highly aggressive tumor entity for which systemic therapies only showed limited efficacy so far. As OSI-027-a dual kinase inhibitor targeting both mTOR complexes, mTORC1...
9.
Lapshyn H, Schulte T, Petruch N, Petrova E, Honselmann K, Deichmann S, et al.
Anticancer Res
. 2021 Oct;
41(10):5123-5130.
PMID: 34593463
Background/aim: The impact of venous resections and reconstruction techniques on morbidity after surgery for pancreatic cancer (PDAC) remains controversial. Patients And Methods: A total of 143 patients receiving pancreatoduodenectomy (PD)...
10.
Lindner K, Binte D, Hoeppner J, Wellner U, Schulte D, Schmid S, et al.
Curr Oncol
. 2021 Aug;
28(4):3071-3080.
PMID: 34436034
Surgery remains the only curative treatment of pancreatic neuroendocrine neoplasms (pNEN). Here, we report the outcome after surgery for non-functional pNEN at a European Neuroendocrine Tumor Society (ENETS) center in...